Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 3CNS 2Other 1

Conditions

Mucositis 9Head and Neck Neoplasms 6Xerostomia 4Squamous Cell Carcinoma of Head and Neck 3Sexual Dysfunction, Physiological 3Stomatitis 2Radiation Injuries 2Prostatic Neoplasms 2Lymphoma 2Sexuality 1Radiotherapy-induced Oral Mucositis 1Radiation-induced Oral Mucositis 1Pain 1Oral Ulcer 1Neurotoxicity Syndromes 1Neoplasms, Plasma Cell 1Neoplasms 1Mouth Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Lung Neoplasms 1Leukemia 1Laryngeal Diseases 1Carcinoma, Squamous Cell 1

Interventions

glucarpidase 1Taxes 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Conformal 1Radiotherapy 1Paclitaxel 1Methotrexate 1Leucovorin 1Carboplatin 1Brachytherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurotoxicity Syndromes × Radiotherapy × Other × Clear all
NCT00727831 2014-01-27

Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma

University College, London

Phase 1/2 Completed
4 enrolled
LymphoidOther

Lymphoma, Lymphoma, Large B-Cell, Diffuse, Neurotoxicity Syndromes, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡